PHARMACEUTICAL COMPOSITIONS
    5.
    发明公开

    公开(公告)号:EP3778623A1

    公开(公告)日:2021-02-17

    申请号:EP20185463.5

    申请日:2014-03-14

    IPC分类号: C07K7/54 A61K38/12

    摘要: The present invention relates to an ionic complex comprising a cationic polypeptide and an anionic excipient selected from: a PEG-carboxylic acid; a fatty acid having 10 or more carbon atoms; an anionic phospholipid; and a combination thereof. The invention also relates to a pharmaceutical composition comprising the ionic complex of the invention and a pharmaceutically acceptable carrier. The cationic polypeptide of the ionic complex has pharmacological activity and the complex can provide a more desirable pharmacokinetic profile for the cationic polypeptide of the complex as compared to the cationic polypeptide alone following administration. As such, the invention also relates to the use of the ionic complex and pharmaceutical composition comprising same to treat a subject suffering from a disease or disorder that is responsive to the cationic polypeptide of the ionic complex.

    PEPTIDE COMPOSITIONS
    7.
    发明公开

    公开(公告)号:EP3450449A2

    公开(公告)日:2019-03-06

    申请号:EP18183527.3

    申请日:2014-03-14

    IPC分类号: C07K7/54 A61K38/12

    摘要: The present invention relates to polypeptide compounds that are modulators (e.g., agonists and antagonists) of the melanocortin-4 receptor (MC4R) and pharmaceutical compositions comprising same. The compounds described herein are polypeptide of the following structural Formula (I): or a pharmaceutically acceptable salt thereof. Values and preferred values of the variables in structural Formula (I) are described herein.